| AuKing Mining Limited (AKN) ORDINARY FULLY PAID |
Materials |
$15 |
Letter to shareholders re AGM
|
28 Apr 2025 8:35AM |
$0.007 |
$0.012 |
risen by
71.43%
|
|
| Brambles Limited (BXB) ORDINARY FULLY PAID |
Industrials |
$31,642 |
Brambles FY25 Third Quarter Trading Update
|
28 Apr 2025 8:35AM |
$20.880 |
$23.300 |
risen by
11.59%
|
|
BXB - Price-sensitive ASX Announcement
Full Release
Key Points
- Sales revenue growth of 3% in the first nine months of FY25.
- Narrowed FY25 sales revenue growth outlook to 4-5%.
- Free Cash Flow upgraded to USD 900 million - 1 billion.
- Challenges in like-for-like volumes due to macroeconomic uncertainties.
- Underlying profit guidance remains unchanged.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aussie Broadband Limited (ABB) ORDINARY FULLY PAID |
Communication Services |
$1,434 |
Update - Notification of buy-back - ABB
|
28 Apr 2025 8:34AM |
$3.910 |
$4.900 |
risen by
25.32%
|
|
| Westgold Resources Limited (WGX) ORDINARY FULLY PAID |
Materials |
$6,765 |
Higginsville Expansion Plan
|
28 Apr 2025 8:34AM |
$3.040 |
$7.160 |
risen by
135.53%
|
|
WGX - Price-sensitive ASX Announcement
Full Release
Key Points
- The HXP Scoping Study evaluates the expansion of the existing Higginsville processing plant from 1.6Mtpa to 2.6Mtpa.
- The expansion is expected to increase steady state annual gold production from 87kozpa to between 122kozpa and 160kozpa.
- The plan will reduce operating costs from approximately 36$/t to 33$/t.
- The capital outlay for the expansion is estimated at around A$92M.
- The project has an internal rate of return of 37% with a payback period of 2.1 years.
- Debottlenecking of the existing mill is already in progress.
- A detailed engineering study will commence to improve accuracy for a financial investment decision in FY26.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Adveritas Limited (AV1) ORDINARY FULLY PAID |
Information Technology |
$92 |
Quarterly Activities Report & Appendix 4C
|
28 Apr 2025 8:34AM |
$0.082 |
$0.100 |
risen by
21.95%
|
|
AV1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly report covers period ending 31 March 2023.
- Adveritas Limited's core product is TrafficGuard, aimed at preventing digital ad fraud.
- Annual recurring revenue increased, demonstrating business growth.
- New clients onboarded and existing relationships expanded during the quarter.
- Expansion into new industry sectors and international markets underway.
- Operational milestones achieved, including platform enhancements and technology integrations.
- Strategic partnerships and marketing initiatives contributed to customer acquisition.
- Appendix 4C outlines statutory cash flows and financial performance for the quarter.
- Company maintains sufficient funding for ongoing operations and future growth.
- Focus remains on scaling the business and increasing market share.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BlinkLab Limited (BB1) ORDINARY FULLY PAID |
Health Care |
$84 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
28 Apr 2025 8:34AM |
$0.360 |
$0.955 |
risen by
165.28%
|
|
BB1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly Activities and Cash Flow Report for the period ended 31 March 2024 released.
- Ongoing development of smartphone-based neurobehavioral and psychiatric disorder diagnostics.
- Initiated clinical validation study of depression test at University of Alberta, Canada.
- Advancement in Japanese market through agreement with Dokeos, with first payment received.
- Received $255K R&D tax incentive in April 2024.
- Completed Share Purchase Plan and placement, raising $1.1 million before costs.
- Cash outflows focused on research and development, staff costs, and administration.
- Cash balance at end of quarter was $1.6 million; anticipated funding for more than two quarters.
- No payments were made to related parties that were not in the ordinary course of business.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| DroneShield Limited (DRO) ORDINARY FULLY PAID |
Industrials |
$2,784 |
Notice of Annual General Meeting/Proxy Form
|
28 Apr 2025 8:34AM |
$1.205 |
$3.030 |
risen by
151.45%
|
|
| AuKing Mining Limited (AKN) ORDINARY FULLY PAID |
Materials |
$15 |
Notice of Annual General Meeting/Proxy Form
|
28 Apr 2025 8:34AM |
$0.007 |
$0.012 |
risen by
71.43%
|
|
| Red Mountain Mining Limited (RMX) ORDINARY FULLY PAID |
Materials |
$26 |
New High Priority Gold Targets Uncovered at WA Gold Project
|
28 Apr 2025 8:34AM |
$0.008 |
$0.028 |
risen by
250%
|
|
RMX - Price-sensitive ASX Announcement
Full Release
Key Points
- Red Mountain Mining Limited identified new high-priority gold targets at Mt Maitland Gold Project in WA.
- Recent ultrafine soil sampling program revealed new gold anomalies.
- Several large and coherent gold-in-soil anomalies have been defined.
- These new targets are in addition to existing gold prospects within the project area.
- Further infill sampling and drilling are planned to test these anomalies.
- The project area is considered highly prospective due to its geological characteristics and historical high-grade gold results.
- Company aims to advance exploration and unlock value at the Mt Maitland project.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mach7 Technologies Limited (M7T) ORDINARY FULLY PAID |
Health Care |
$83 |
Update - Notification of buy-back - M7T
|
28 Apr 2025 8:34AM |
$0.325 |
$0.355 |
risen by
9.23%
|
|
| Clever Culture Systems Limited (CC5) ORDINARY FULLY PAID |
Health Care |
$63 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
28 Apr 2025 8:34AM |
$0.016 |
$0.029 |
risen by
81.25%
|
|
CC5 - Price-sensitive ASX Announcement
Full Release
Key Points
- CCS continued the commercialization of the APAS Independence instrument during the quarter ended 31 March 2023.
- Significant placements of APAS in US laboratories and progress in international markets were reported.
- Development and release of new software modules, enhancing APAS instrument capabilities.
- Increased revenue over the previous quarter due to greater market adoption.
- Operating cash outflows increased, mainly from higher product development and commercialization costs.
- CCS held a strong cash position by the end of the quarter to support continued development and growth.
- The company remains focused on expanding its market presence and advancing its artificial intelligence technologies.
- Appendix 4C details cash flows, including receipts, operating costs, investing, and financing activities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Litchfield Minerals Limited (LMS) ORDINARY FULLY PAID |
Materials |
$37 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
28 Apr 2025 8:33AM |
$0.140 |
$0.635 |
risen by
353.57%
|
|
LMS - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly report covers the period ending 30 June 2023.
- Significant exploration activities conducted at the Litchfield Project in the Northern Territory.
- Focus on lithium and tantalum target areas with continued fieldwork and planning of further drilling campaigns.
- Completion of mapping and sampling programs to define drill targets.
- Appendix 5B details cash flows, including expenditures on exploration and evaluation activities.
- Company maintains a focus on prudent cash management and reports sufficient cash for planned activities.
- Future plans include further drilling and ongoing assessment of project potential.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Capricorn Metals Ltd (CMM) ORDINARY FULLY PAID |
Materials |
$6,045 |
Quarterly Exploration Update
|
28 Apr 2025 8:33AM |
$9.150 |
$13.250 |
risen by
44.81%
|
|
CMM - Price-sensitive ASX Announcement
Full Release
Key Points
- Capricorn Metals Ltd reported significant drilling results at the Highway area.
- Exploration activities included 835 holes drilled covering 34,390 metres.
- Drilling at the Aries deposit validated historical data leading to a maiden resource estimate.
- Further drilling identified high-grade mineralization beneath the Orion pit.
- Capricorn expanded its tenement holdings with acquisitions in the Pilbara region.
- Ongoing exploration aims to support underground mining potential with a maiden MRE planned for Q1 FY26.
- The quarterly update highlights new drilling results showing extensive gold mineralization.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Vita Life Sciences Limited (VLS) ORDINARY FULLY PAID |
Health Care |
$142 |
Notification of cessation of securities - VLS
|
28 Apr 2025 8:33AM |
$1.750 |
$2.600 |
risen by
48.57%
|
|
| Telix Pharmaceuticals Limited (TLX) ORDINARY FULLY PAID |
Health Care |
$2,968 |
Telix Provides Regulatory Update on TLX101-CDx
|
28 Apr 2025 8:33AM |
$28.560 |
$8.760 |
fallen by
69.33%
|
|
TLX - Price-sensitive ASX Announcement
Full Release
Key Points
- Telix Pharmaceuticals received a Complete Response Letter from the U.S. FDA for TLX101-CDx.
- The FDA requires additional confirmatory clinical evidence for the NDA to progress.
- There were no safety concerns raised by the FDA regarding TLX101-CDx.
- The company plans to request a hearing with the FDA to discuss the decision.
- Telix remains committed to addressing the unmet medical need for glioma imaging.
- TLX101-CDx has received Orphan Drug and Fast Track designations from the FDA.
- The outcome does not affect Telix's financial guidance for 2025.
- Telix will continue providing access to TLX101-CDx via the FDA-approved expanded access program.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Qoria Limited (QOR) ORDINARY FULLY PAID |
Information Technology |
$420 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
28 Apr 2025 8:33AM |
$0.355 |
$0.310 |
fallen by
12.68%
|
|
QOR - Price-sensitive ASX Announcement
Full Release
Key Points
- Qoria Limited reported continued growth in SaaS recurring revenue for the quarter ended 30 June 2023.
- Customer onboarding remained strong, particularly in schools across Australia, New Zealand, the United States, and the United Kingdom.
- Strategic acquisitions were completed to expand the company’s product portfolio and market reach.
- Geographical expansion included further penetration into the US and UK education sectors.
- Customer retention rates remained high, reflecting satisfaction with Qoria's offerings.
- Product development efforts were intensified to enhance platform features and scalability.
- The company implemented ongoing cost management initiatives to improve operational efficiency.
- The Appendix 4C Cash Flow Report showed inflows from customers, investment in product development, administrative expenses, and acquisition costs.
- Qoria closed the quarter with a healthy cash balance, providing financial flexibility for future growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| L1 Long Short Fund Limited (LSF) ORDINARY FULLY PAID |
Financials |
$2,633 |
Net Tangible Asset Backing
|
28 Apr 2025 8:33AM |
$2.650 |
$4.160 |
risen by
56.98%
|
|
| ClearVue Technologies Limited (CPV) ORDINARY FULLY PAID |
Industrials |
$40 |
Quarterly Activities Report and Appendix 4C
|
28 Apr 2025 8:33AM |
$0.200 |
$0.130 |
fallen by
35%
|
|
CPV - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly Activities Report for ClearVue Technologies for the quarter ending 30 June 2023.
- Significant progress in US market expansion and commercial partnerships.
- Engagement in key projects, including installations in US schools and demonstration sites.
- Advancements in product certifications and technical development of PV window technologies.
- Cash receipts from customers for the quarter totaled AUD 177K.
- Research and development expenditures and operational outflows are detailed.
- Company maintains focus on global commercialization and prudent capital management.
- ClearVue continues to develop new product offerings and expand its partner network.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Develop Global Limited (DVP) ORDINARY FULLY PAID |
Materials |
$1,756 |
Quarterly Appendix 5B Cash Flow Report
|
28 Apr 2025 8:33AM |
$2.700 |
$5.320 |
risen by
97.04%
|
|
DVP - Price-sensitive ASX Announcement
Full Release
Key Points
- Develop Global Limited (DVP) released its Quarterly Activities and Appendix 5B Cash Flow Report for the period ending 31 December 2023.
- The report covers operational progress at the Woodlawn Project, including feasibility studies and permitting activities.
- Positive results were noted from recent metallurgical, geotechnical, and other technical studies at Woodlawn.
- The report details cash flows, including exploration, development, and administrative expenditures.
- The company's cash position at the end of the quarter is disclosed, along with expected spending for the next quarter.
- Updates are provided on both the Woodlawn and Sulphur Springs projects.
- Corporate events and strategic initiatives during the quarter are summarized.
- The Appendix 5B details company cash movements and balances.
- The report is intended for shareholders and stakeholders to provide transparency on financial and operational progress.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bravura Solutions Limited (BVS) ORDINARY FULLY PAID |
Information Technology |
$932 |
CEO Change
|
28 Apr 2025 8:33AM |
$2.230 |
$2.080 |
fallen by
6.73%
|
|
BVS - Price-sensitive ASX Announcement
Full Release
Key Points
- Bravura Solutions Limited (BVS) announced the appointment of Mr. Andrew Russell as CEO effective immediately.
- The change follows the departure of former CEO Ms. Libby Roy.
- Mr. Russell brings extensive experience in technology and financial services.
- The Board expressed confidence in Mr. Russell’s ability to lead the company’s next phase.
- The announcement includes thanks and recognition for Ms. Roy’s service and contributions to the company.
- Details about the succession planning and transition process are provided.
- The company reiterated its ongoing business priorities and strategic direction under new leadership.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Develop Global Limited (DVP) ORDINARY FULLY PAID |
Materials |
$1,756 |
Quarterly Activities Report
|
28 Apr 2025 8:33AM |
$2.700 |
$5.320 |
risen by
97.04%
|
|
DVP - Price-sensitive ASX Announcement
Full Release
Key Points
- Progress at the Sulphur Springs Copper-Zinc Project with feasibility and permitting activities ongoing.
- Continued exploration and drilling in the Greater Sulphur Springs area.
- Completion of the acquisition of Essential Metals Limited, adding lithium projects to the portfolio.
- Mining services division maintained strong revenue and contract pipeline.
- Company remains well-funded with robust cash position at quarter end.
- Focus on advancing resource project portfolio and leveraging mining services for growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Magellan Financial Group Limited (MFG) ORDINARY FULLY PAID |
Financials |
$1,354 |
Update - Notification of buy-back - MFG
|
28 Apr 2025 8:33AM |
$7.630 |
$8.060 |
risen by
5.64%
|
|
| FleetPartners Group Limited (FPR) ORDINARY FULLY PAID |
Financials |
$568 |
FY25 Half Year Results Release Date
|
28 Apr 2025 8:33AM |
$2.730 |
$2.630 |
fallen by
3.66%
|
|
| GreenX Metals Limited (GRX) ORDINARY FULLY PAID |
Materials |
$314 |
Tannenberg Copper Project in Germany Expanded to 1,900km2
|
28 Apr 2025 8:33AM |
$0.755 |
$1.010 |
risen by
33.77%
|
|
GRX - Price-sensitive ASX Announcement
Full Release
Key Points
- GreenX Metals Limited expanded the Tannenberg Copper Project licence area to about 1,900 km².
- The project is now one of the largest copper exploration holdings in the European Union.
- Located in Saxony, Germany, the region is mining-friendly with established infrastructure.
- The expanded licence area covers multiple historic copper mining districts with documented past production.
- Evidence of cobalt mineralisation exists within the expanded project area.
- GreenX holds 100% of the project interest.
- The company plans to apply modern exploration techniques to evaluate copper and cobalt potential.
- Expansion aligns with growing EU demand and strategic importance of critical metals supply.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Native Mineral Resources Holdings Limited (NMR) ORDINARY FULLY PAID |
Materials |
$105 |
Major site works completed at Blackjack Gold Project
|
28 Apr 2025 8:33AM |
$0.155 |
$0.096 |
fallen by
38.06%
|
|
Call 1300 880 160
Start a chat
Schedule a call
